Lathrop Investment Management Co. Acquires 26,966 Shares of CVS Health Corporation $CVS

Lathrop Investment Management Co. increased its holdings in CVS Health Corporation (NYSE:CVS) by 31.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,570 shares of the pharmacy operator’s stock after purchasing an additional 26,966 shares during the period. CVS Health makes up 1.6% of Lathrop Investment Management Co.’s investment portfolio, making the stock its 28th biggest holding. Lathrop Investment Management Co.’s holdings in CVS Health were worth $8,411,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its stake in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the period. Corundum Trust Company INC acquired a new position in shares of CVS Health in the third quarter valued at $29,000. Front Row Advisors LLC boosted its stake in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares in the last quarter. Twin Peaks Wealth Advisors LLC bought a new position in CVS Health in the 2nd quarter valued at $36,000. Finally, SOA Wealth Advisors LLC. boosted its stake in CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS opened at $79.74 on Monday. The company has a fifty day moving average price of $78.39 and a 200 day moving average price of $77.29. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The firm has a market cap of $101.44 billion, a PE ratio of 57.78, a PEG ratio of 0.83 and a beta of 0.49. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is 192.75%.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Mizuho raised their price objective on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. Piper Sandler reiterated an “overweight” rating and set a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Sanford C. Bernstein reissued a “market perform” rating and set a $91.00 price objective on shares of CVS Health in a report on Tuesday, January 6th. Finally, Wolfe Research lifted their price objective on shares of CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, December 8th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.